Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03151798 · ClinicalTrials.gov registry record · NA

The Liver Health Study for Patients with NAFLD

A NA study, sponsored by University of Missouri-Columbia.

Completed
Registry status
NA
Development phase
336
Enrollment target

NCT03151798 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 336 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03151798, a NA study, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
NA
Development phase
336 participants
Enrollment target

Study Summary

The study will investigate whether the level of fat stored in the liver is related to the liver's ability to burn fat.

Interventions

  • BEHAVIORAL Phase II: Lifestyle treatment
  • BEHAVIORAL Phase II: Control treatment
  • OTHER Phase I: Observational studies

Trial Details

FieldValue
Enrollment Target 336 participants
Start Date 2017-08-09
Est. Completion 2023-04-29
Phase NA

Sponsor

University of Missouri-Columbia

291 total trials

What the Registry Record Tells You About NCT03151798

The ClinicalTrials.gov registry entry for NCT03151798 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 336 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Phase II: Lifestyle treatment is the first listed.

NCT03151798 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03151798 about?

NCT03151798 is a clinical study titled "The Liver Health Study for Patients with NAFLD". The study will investigate whether the level of fat stored in the liver is related to the liver's ability to burn fat.

What is the current status of trial NCT03151798?

This trial is currently completed. It is a NA study. The enrollment target is 336 participants. The study started on 2017-08-09. Estimated completion is 2023-04-29.

What interventions are being tested in trial NCT03151798?

The interventions under investigation include: Phase II: Lifestyle treatment (BEHAVIORAL), Phase II: Control treatment (BEHAVIORAL), Phase I: Observational studies (OTHER).

Who is sponsoring clinical trial NCT03151798?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.